Literature DB >> 31059856

Revascularization Surgery in Patients with Ischemic-Type Moyamoya Disease: Predictors for Postoperative Stroke and Long-Term Outcomes.

Lebao Yu1, Li Ma1, Zheng Huang2, Zhiyong Shi1, Rong Wang1, Yuanli Zhao1, Dong Zhang1.   

Abstract

BACKGROUND: Recurrent stroke after surgical revascularization is still a big issue for moyamoya disease (MMD). This study aims to identify predictors for postoperative stroke and unfavorable outcome in ischemic-type MMD.
METHODS: We identified a consecutive series of patients with ischemic-type MMD who underwent revascularization between January 2005 and December 2012. Predictors for postoperative stroke and functional outcomes were assessed with logistic and Cox regression analysis.
RESULTS: A total of 346 patients underwent 437 revascularization procedures and the mean follow-up period was 4.0 years. The incidence of perioperative stroke was 6.9%. Being adult at onset (odds ratio [OR], 5.033; 95% confidence interval [CI], 1.447-17.506; P = 0.011) and posterior cerebral artery (PCA) stenosis (OR, 3.364; 95% CI, 1.588-7.265; P = 0.002) before surgery were predictors of perioperative stroke. The annual subsequent stroke rate beyond 30 days after surgery was 1.2%. Subsequent stroke events tended to occur throughout the first 5 years after surgery in adults, whereas in children they mainly occurred within the first 2 years after surgery. Age at onset (OR, 1.025; 95% CI, 1.003-1.048; P = 0.023), ischemic stroke or transient ischemic attack at presentation (OR, 2.703; 95% CI, 1.062-6.875; P = 0.037), and PCA involvement (OR, 2.664; 95% CI, 1.462-4.854; P = 0.001) were associated with higher risk of overall postoperative stroke. PCA involvement (OR, 2.62; 95% CI, 1.33-5.15; P = 0.005), internal carotid artery supraclinoid segment occlusion (OR, 2.76; 95% CI, 1.27-6.03; P = 0.011), and older age at onset (OR, 1.03; 95% CI, 1.01-1.05; P = 0.033) were predictive of unfavorable outcome.
CONCLUSIONS: Patients with ischemic-type MMD at an older age and more severe angiopathy might be at higher risk of recurrent stroke and unfavorable outcome after revascularization.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cerebral ischemia; Moyamoya disease; Outcome; Revascularization; Stroke

Mesh:

Year:  2019        PMID: 31059856     DOI: 10.1016/j.wneu.2019.04.214

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  5 in total

1.  Postoperative stroke and neurological outcomes in the early phase after revascularization surgeries for moyamoya disease: an age-stratified comparative analysis.

Authors:  Yoshio Araki; Kinya Yokoyama; Kenji Uda; Fumiaki Kanamori; Michihiro Kurimoto; Yoshiki Shiba; Takashi Mamiya; Masahiro Nishihori; Takashi Izumi; Masaki Sumitomo; Sho Okamoto; Kota Matsui; Ryo Emoto; Toshihiko Wakabayashi; Shigeyuki Matsui; Atsushi Natsume
Journal:  Neurosurg Rev       Date:  2021-01-08       Impact factor: 3.042

2.  Hyperhomocysteinemia is a risk factor for postoperative ischemia in adult patients with moyamoya disease.

Authors:  Junsheng Li; Peicong Ge; Qian Zhang; Fa Lin; Rong Wang; Yan Zhang; Dong Zhang; Wen Wang; Jizong Zhao
Journal:  Neurosurg Rev       Date:  2021-01-27       Impact factor: 3.042

3.  Surgical revascularization for Moyamoya disease in the United States: A cost-effectiveness analysis.

Authors:  Arvin R Wali; David R Santiago-Dieppa; Shanmukha Srinivas; Michael G Brandel; Jeffrey A Steinberg; Robert C Rennert; Ross Mandeville; James D Murphy; Scott Olson; J Scott Pannell; Alexander A Khalessi
Journal:  J Cerebrovasc Endovasc Neurosurg       Date:  2021-02-05

4.  Daily Remote Ischemic Conditioning Can Improve Cerebral Perfusion and Slow Arterial Progression of Adult Moyamoya Disease-A Randomized Controlled Study.

Authors:  Jiali Xu; Qian Zhang; Gary B Rajah; Wenbo Zhao; Fang Wu; Yuchuan Ding; Bowei Zhang; Wenting Guo; Qi Yang; Xiurong Xing; Sijie Li; Xunming Ji
Journal:  Front Neurol       Date:  2022-02-03       Impact factor: 4.003

Review 5.  Limits and pitfalls of indirect revascularization in moyamoya disease and syndrome.

Authors:  Pietro Fiaschi; Marcello Scala; Gianluca Piatelli; Domenico Tortora; Francesca Secci; Armando Cama; Marco Pavanello
Journal:  Neurosurg Rev       Date:  2020-09-21       Impact factor: 3.042

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.